(Q35191450)

7 August 2017

title

Pharmacokinetic modeling of plasma and intracellular concentrations of raltegravir in healthy volunteers (English)

1 reference

7 August 2017

1 reference

1 reference

Lingzhi Wang

1

1 reference

7 August 2017

Gaik Hong Soon

2

1 reference

7 August 2017

Kok-Yong Seng

3

1 reference

7 August 2017

Jun Li

4

1 reference

7 August 2017

Edmund Lee

5

1 reference

7 August 2017

Eu-Leong Yong

6

1 reference

7 August 2017

Boon-Cher Goh

7

1 reference

7 August 2017

Charles Flexner

8

1 reference

7 August 2017

Lawrence Lee

9

1 reference

7 August 2017

language of work or name

English

0 references

publication date

11 July 2011

1 reference

Antimicrobial Agents and Chemotherapy

7 August 2017

number of pages

6

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

7 August 2017

volume

55

1 reference

7 August 2017

issue

9

1 reference

7 August 2017

page(s)

4090-4095

1 reference

Evaluation of the mean corpuscular volume of peripheral blood mononuclear cells of HIV patients by a coulter counter to determine intracellular drug concentrations.

7 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3165315

Plasma and intracellular (peripheral blood mononuclear cells) pharmacokinetics of once-daily raltegravir (800 milligrams) in HIV-infected patients

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3165315

Raltegravir: a review of its pharmacokinetics, pharmacology and clinical studies

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3165315

Intracellular and plasma steady-state pharmacokinetics of raltegravir, darunavir, etravirine and ritonavir in heavily pre-treated HIV-infected patients

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3165315

Raltegravir with optimized background therapy for resistant HIV-1 infection

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3165315

Integrase inhibitors to treat HIV/AIDS.

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3165315

Safety and efficacy of raltegravir-based versus efavirenz-based combination therapy in treatment-naive patients with HIV-1 infection: a multicentre, double-blind randomised controlled trial

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3165315

Pharmacokinetics of raltegravir in individuals with UGT1A1 polymorphisms

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3165315

Effects of omeprazole on plasma levels of raltegravir

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3165315

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3165315

Lack of a pharmacokinetic effect of raltegravir on midazolam: in vitro/in vivo correlation

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3165315

Metabolism and disposition in humans of raltegravir (MK-0518), an anti-AIDS drug targeting the human immunodeficiency virus 1 integrase enzyme

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3165315

Safety and efficacy of the HIV-1 integrase inhibitor raltegravir (MK-0518) in treatment-experienced patients with multidrug-resistant virus: a phase II randomised controlled trial

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3165315

Population pharmacokinetics of efavirenz in an unselected cohort of HIV-1-infected individuals

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3165315

Antiretroviral activity, pharmacokinetics, and tolerability of MK-0518, a novel inhibitor of HIV-1 integrase, dosed as monotherapy for 10 days in treatment-naive HIV-1-infected individuals

27 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21746959

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Simultaneous determination of raltegravir and raltegravir glucuronide in human plasma by liquid chromatography-tandem mass spectrometric method

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21746959

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1128/AAC.00593-11

1 reference

7 August 2017

1 reference

7 August 2017

1 reference